Yasmeen Shamsi | Hypertension | Best Researcher Award

Prof Yasmeen Shamsi, Jamia Hamdard, India

Yasmeen Shamsi is a prominent researcher in the field of hypertension. She has made significant contributions to our understanding of high blood pressure and its management, which has earned her accolades and recognition in the scientific community. Her research often focuses on the mechanisms underlying hypertension, innovative treatment approaches, and the impact of lifestyle factors on blood pressure regulation.

Profile:

Scopus Profile

Education:

Yasmeen Shamsi earned her Bachelor of Unani Medicine and Surgery (BUMS) degree from Aligarh Muslim University (AMU), Aligarh, Uttar Pradesh, in 1987. She further pursued advanced studies at Jamia Hamdard in New Delhi, where she completed her Doctor of Medicine (MD) in Moalajat, a branch of Unani medicine, in 2003.

Teaching Experience:

Dr. Yasmeen Shamsi has a distinguished career in medical education, with significant contributions as a clinical educator and researcher. From 1995 to 2001, she served as a Clinical Registrar at Majeedia Hospital, providing valuable clinical demonstrations to interns and students. She taught Tashreeh-wo-Munafaul Aza (Anatomy & Physiology) to B.U.M.S. first-year students at Jamia Hamdard from July to December 1999. Following this, Dr. Shamsi taught Ummor-e-Tabiya to first-year B.U.M.S. students at Jamia Hamdard from October 2001 to December 2012. Since January 2013, she has been instructing B.U.M.S. second-year students in Ilmul Amraz and B.U.M.S. third-year students, as well as MD (Moalajat) students in Moalajat, continuing her impactful teaching at Jamia Hamdard.

Research Experience:

Dr. Yasmeen Shamsi has dedicated over 22 years to clinical research, focusing on a wide array of topics. As a Principal Investigator, she led several significant research projects at HNF, New Delhi. From 2000 to 2002, she examined the effects of Dam-Tab on blood glucose levels in Type-II diabetes mellitus patients and assessed the clinical efficacy of Marham Muhasa in treating acne vulgaris. Her research continued from 2001 to 2005, evaluating the pharmacological effects of Lipotab on lipoprotein levels, and a placebo-controlled, double-blind randomized trial of Qurs-e-Mafasil in rheumatoid arthritis. Between 2003 and 2006, she investigated the impact of Hairi oil and Hairi Plus oil on hair loss. Her subsequent projects, from 2006 to 2009, included a clinical study of Dawa-e-Musakkin for generalized anxiety disorder and an evaluation of Hamdoroid Capsule & Hamdoroid Ointment for hemorrhoids. She also studied the efficacy of a herbal formulation, ‘Diabeat,’ as an adjunct for controlling Type-2 diabetes mellitus from 2007 to 2011.

In her role as a Co-Investigator from 1995 to 1998 at HNF, New Delhi, Dr. Shamsi contributed to studies on Pitkirya Capsules for urticaria treatment, Entropher Tablets for irritable bowel syndrome, and the effectiveness of Qurs Supari Pak Jadeed and Unishaf Pessary for leucorrhoea associated with cervicitis and cervical erosion. Additionally, she co-investigated the clinical trial of Jigreen Syrup and Jigreen Tablet against viral hepatitis.

Top Notable Publications:

“Hijāmah (Cupping Therapy) for Pain Management in Patients with Cervical Spondylosis”
Khan, R., Shamsi, Y., Khan, S.A., Nikhat, S., & Akhtar, W.
Alternative Therapies in Health and Medicine, 2023, 29(7), pp. 268–271.

“Clinical Evaluation of a Topical Unani Pharmacopoeial Formulation Tila-e-Kalf in the Management of Melasma (Kalf): A Randomized Controlled Clinical Trial”
Salma, Shamsi, Y., Nikhat, S., Akhtar, Md.W., & Ahmad, S.
Avicenna Journal of Phytomedicine, 2023, 13(3), pp. 255–264.

“A Polyherbal Formulation Habb-e-Ustukhuddus Induces Apoptosis and Inhibits Cell Migration in Lung and Breast Cancer Cells without Any Toxicity in Mice”
Punia, R., Ali, M., Shamsi, Y., & Singh, R.P.
Asian Pacific Journal of Cancer Prevention, 2023, 24(8), pp. 2713–2727.

“Role of AMP-Activated Protein Kinase on Cardio-Metabolic Abnormalities in the Development of Diabetic Cardiomyopathy: A Molecular Landscape”
Haye, A., Ansari, M.A., Rahman, S.O., Ahmed, D., & Sharma, M.
European Journal of Pharmacology, 2020, 888, 173376.

“Cichorium intybus Attenuates Streptozotocin Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Inflammatory Response in Rats”
Sharma, M., Afaque, A., Dwivedi, S., Khan, M.I., Ahmed, D.
Interdisciplinary Toxicology, 2019, 12(3), pp. 111–119.

“Clinically Significant Improvement in a Case of Bronchial Asthma with Unani Medicine: A Case Report”
Shamsi, Y., Khan, R., & Nikhat, S.
Traditional and Integrative Medicine, 2019, 4(4), pp. 130–136.

“Siris (Albizzia lebbeck (L.) Benth.) in View of Unani and Contemporary Pharmacology”
Khan, S., Shamsi, Y., & Jahangir, U.
International Journal of Green Pharmacy, 2018, 12(2), pp. S306–S314.

Prof. Jeanette Woolard | Hypertension | Best Researcher Award

University of Nottingham, United Kingdom

Prof. Jeanette Woolard, based at the University of Nottingham in the UK, is a distinguished expert in the field of Hypertension. With a notable academic career, Prof. Woolard has made significant contributions to hypertension research, advancing our understanding of cardiovascular health. Her work extends to both scholarly pursuits and practical applications in the field. As a respected figure in hypertension studies, Prof. Woolard continues to shape the landscape of cardiovascular research through her expertise, dedication, and commitment to improving health outcomes related to hypertension. Her influence extends beyond academia, positively impacting the broader medical community.

Professional Profile

Scopus

Education

Prof. Jeanette Woolard, is a distinguished scholar with a robust academic background. She earned her Ph.D. in Pharmacology and Physiology from the University of Nottingham, UK (1999-2002), showcasing her dedication to advancing medical knowledge. 🎓 Prior to this, she pursued an MSc in Cardiovascular Pharmacology at Queen’s University, Canada (1997-1999), honing her expertise in cardiovascular health. 🍁 Her academic journey began with a stellar BSc (Hons) in Life Sciences (Class I) at Queen’s University, Canada (1993-1997), setting the stage for a prolific career. Dr. [Name]’s academic milestones underscore her commitment to excellence in pharmacology and physiology. ✨

Honours and Awards

Prof. Jeanette Woolard, a trailblazing figure, has garnered significant recognition for her contributions to pharmacology and academia. In 2022, she received the prestigious Equity, Diversity, and Inclusion Prize from the British Pharmacological Society, sponsored by AstraZeneca, highlighting her commitment to promoting a diverse and inclusive scientific community. 🌐 Her accomplishments led to a Fellowship with the British Pharmacological Society in 2020, and she was honored with the University of Nottingham’s Vice Chancellor’s Award in the same year, acknowledging her outstanding contribution to Team Science. 🏆 Prof. Woolard’s dedication to teaching was recognized with the 2019 Staff Oscar Teaching Award for being the best dissertation supervisor. 🎓 Additionally, her influential work earned her the Bill Bowman Prize Lectureship in 2018, one of the British Pharmacological Society’s prestigious awards based on published work and a compelling lecture synopsis. 🏅

Patents

Prof. Jeanette Woolard’s impactful contributions extend to groundbreaking research in the field of cardiac and cardiovascular disease. In collaboration with a team, she co-authored a significant patent titled “Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease” at the University of Nottingham, UK. 🌐 The patent, documented under US20140094493 A1 (2014), WO2012104659A1 (2012), and EP2670734A1 (2013), underscores her commitment to advancing treatments in cardiovascular health. 🩺 This innovative work not only reflects her expertise in the domain but also positions Prof. Woolard as a key figure in the quest for novel therapeutic approaches to address cardiac and cardiovascular challenges. 🏅